Fizyhealth
RxFul company profile

RxFul company profile: what is public, what is not

RxFul is white-label pharmacy infrastructure at rxful.com — clinic-branded patient portals, licensed 503A partner orchestration, tiered SaaS, and bundled 3PL fulfillment. Beyond the product, RxFul does not publish ownership, leadership, funding, headquarters, or customer-count details on its public site as of June 2026, so this profile reports only what can be verified and flags the rest as undisclosed.

If you are doing vendor due diligence on RxFul as a company, this page separates the publicly verifiable facts from the details RxFul does not disclose — without filling the gaps with guesses.

Compare Fizy Health vs RxFul

Proudly Partnered With

What is publicly verifiable about RxFul?

What can be verified from RxFul's public materials is the product and its model: RxFul is a white-label pharmacy infrastructure platform at rxful.com that provides clinic-branded patient portals, licensed 503A partner orchestration, regulated 3PL fulfillment, and tiered SaaS from $0 GLP through $1,997 per month. It also advertises a separate 503B office-use pathway, an affiliate program, and explicit language that RxFul does not prescribe, dispense, or hold pharmacy licensure. What is not on the public site, as of June 2026, is corporate detail: ownership, leadership names, funding history, headquarters, named 503A partner pharmacies, and customer or order counts are not disclosed.

Who needs this profile

Due diligence falls to the people signing the contract.

A company profile matters most to the roles responsible for vendor risk before a clinic commits. Three of them carry that weight.

  • Owners

    Founders accepting vendor risk.

    Owners sign the agreement, so they carry the risk of a vendor whose corporate details are not public. Their question is what can be confirmed about the company's stability and standing, and what to request directly when the website is silent on ownership and funding.

  • Operators

    Ops leads assessing reliability.

    Operations staff depend on fulfillment infrastructure daily, so company longevity and support responsiveness matter. With customer counts and funding undisclosed, they evaluate reliability through contract terms, onboarding references, and fulfillment track record rather than published metrics.

  • Prescribers

    Providers confirming legitimacy.

    Prescribers want assurance the platform routes to legitimate, licensed 503A pharmacies. Since RxFul does not publish a partner list on rxful.com, due diligence centers on verifying the certification and licensure of the pharmacies behind each order during onboarding.

What RxFul does not publish

As of June 2026, rxful.com does not disclose who owns RxFul, the names of its leadership, whether it has raised outside funding, where it is headquartered, or how many clinics use the platform. It also does not name the specific 503A partner pharmacies it orchestrates or publish aggregate order volumes. RxFul does not list a public support phone number or email on the marketing site — onboarding flows through the site's compliance and sales CTAs instead.

This is common for privately held infrastructure vendors and is not, by itself, a red flag. But it does mean a clinic's due diligence has to come from direct requests rather than the website. The absence of public corporate detail shifts where you get your answers.

What to ask RxFul directly

Because corporate facts are not public, request them in the onboarding conversation: ask which legal entity you are contracting with, who stands behind the platform, and how long it has operated. Ask for the specific 503A partner pharmacies your clinic would route to and proof of their state licensure, since the platform's legitimacy ultimately rests on its partners. Ask for references from clinics like yours, and read the contract, cancellation terms, and fulfillment SLAs before signing.

On the parts you can verify yourself, confirm rxful.com describes white-label infrastructure with published tiered SaaS, states RxFul does not hold pharmacy licensure, and separates 503A mail-order from 503B office-use compliance. For a transparent point of comparison, Fizy Health publishes its prescriber ordering model openly — pass-through per-vial 503A pricing before checkout, a disclosed facilitation fee, and LegitScript-certified partners.

After due diligence — which platform fits your clinic?

RxFul fits if

RxFul

Patient-brand infrastructure is the primary requirement.

  • You are satisfied with what RxFul confirms directly about its company, 503A partners, and fulfillment SLAs.
  • Clinic-branded patient checkout with tiered SaaS and bundled 3PL is your primary need — not prescriber batch carts.
  • Prescriber-side refill-day batching is a secondary concern behind launching patient-facing portal infrastructure.
Consider Fizy Health if

Fizy Health

You want landed cost before the consult — and validation before you pay.

  • You want a vendor that publishes its prescriber ordering model and pass-through pricing approach openly.
  • You order GLP-1, hormone, or peptide refills at volume and need one cart with validation before payment.
  • You batch refills across multiple 503A partners and want per-vial cost visible before checkout.
If you choose Fizy Health

What your clinic gets from a transparent prescriber platform.

RxFul and Fizy Health both connect clinics to 503A partners. These outcomes show up when pricing and the partner model are visible before you commit.

See all features
Keep evaluating RxFul

More answers in the RxFul evaluation guide.

See the full RxFul guide
FAQ

Company questions clinics ask about RxFul.

  • Company

    What is RxFul as a company?

    RxFul is a white-label pharmacy infrastructure platform at rxful.com providing clinic-branded patient portals, 503A partner orchestration, tiered SaaS, and 3PL fulfillment. That product model is publicly verifiable; broader corporate details are not published as of June 2026.

  • Ownership

    Who owns RxFul?

    RxFul does not publish ownership or leadership information on rxful.com as of June 2026. If ownership matters to your due diligence, ask which legal entity you are contracting with during onboarding.

  • Funding

    Has RxFul raised funding?

    RxFul does not disclose funding history on its public site as of June 2026. There is no verifiable public record to cite here, so we report it as undisclosed rather than guess at investors or amounts.

  • Customers

    How many clinics use RxFul?

    RxFul does not publish customer or order counts as of June 2026. Ask RxFul directly for references from clinics like yours and for the partner pharmacies your orders would route to.

  • Diligence

    What should I verify before signing with RxFul?

    Confirm the contracting entity, the specific 503A partner pharmacies and their state licensure, fulfillment SLAs, references from comparable clinics, and contract and cancellation terms. The platform's legitimacy rests on its licensed partners.

  • Alternative

    How transparent is Fizy Health by comparison?

    Fizy Health publishes its prescriber ordering model openly: pass-through per-vial 503A pricing shown before checkout, a disclosed facilitation fee, LegitScript-certified partners, and a BAA at onboarding.

Sources reviewed June 2026

  • RxFul public website (rxful.com), reviewed June 2026. Ownership, funding, customer counts, named partner pharmacies, and public support contact are not disclosed on the site as of this date.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Choose a platform that shows its model up front.

See how Fizy Health shows landed cost before you quote, batches refill day in one cart, and validates orders before you pay. Free to start.

Fizy Health vs RxFulStart Ordering Free